Journal article · 2020

Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response

Wen Liu, Yuki Takahashi, Masaki Morishita, Makiya Nishikawa, Yoshinobu Takakura

Nanomedicine, 15(17), 1641–1652 · Published 1 July 2020 · DOI 10.2217/nnm-2020-0071

View at the publisherCite this paper

In brief

“Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response” is a 2020 journal article by Wen Liu and 4 co-authors, published in Nanomedicine. OpenAlex counts 17 citations as of 19 November 2026, which puts it in the top 9% of works published in 2020 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
17
Most cited in
2021 (7)
Field-weighted impact
0.87
References
27
Authors
5

Abstract

Aim: Tumor-derived small extracellular vesicles (TEVs) are considered for use in inducing tumor antigen-specific immune responses as they contain tumor antigens. The delivery of tumor antigens to the antigen presentation cells (especially dendritic cells [DCs]), and the activation of DCs are the main challenges of TEV therapy. Materials & methods: TEVs were modified with CD40… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Liu, W., Takahashi, Y., Morishita, M., Nishikawa, M., & Takakura, Y. (2020). Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response. Nanomedicine, 15(17), 1641–1652. https://doi.org/10.2217/nnm-2020-0071

MLA 9

Liu, Wen, et al. “Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response.” Nanomedicine, vol. 15, no. 17, 2020, pp. 1641–1652. https://doi.org/10.2217/nnm-2020-0071.

Chicago

Liu, Wen, Yuki Takahashi, Masaki Morishita, Makiya Nishikawa, and Yoshinobu Takakura. 2020. “Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response.” Nanomedicine 15 (17): 1641–1652. https://doi.org/10.2217/nnm-2020-0071.

Harvard

Liu, W. et al. (2020) ‘Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response’, Nanomedicine, 15(17), pp. 1641–1652. doi:10.2217/nnm-2020-0071.

IEEE

W. Liu, Y. Takahashi, M. Morishita, M. Nishikawa, and Y. Takakura, “Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response,” Nanomedicine, vol. 15, no. 17, pp. 1641–1652, 2020, doi: 10.2217/nnm-2020-0071.

BibTeX

@article{liu2020development,
  title     = {{Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response}},
  author    = {Liu, Wen and Takahashi, Yuki and Morishita, Masaki and Nishikawa, Makiya and Takakura, Yoshinobu},
  journal   = {Nanomedicine},
  year      = {2020},
  volume    = {15},
  number    = {17},
  pages     = {1641--1652},
  doi       = {10.2217/nnm-2020-0071},
  url       = {https://doi.org/10.2217/nnm-2020-0071}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202177
202222
202344
202433
202611

Its field-weighted citation impact is 0.87: it has been cited 0.87 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease

  • tumor-derived extracellular vesicles
  • CD40 ligand
  • CD40-CD40L interaction
  • dendritic cell activation
  • tumor antigen presentation
  • cancer vaccination
  • antitumor immunity

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Liu, W., Takahashi, Y., Morishita, M., Nishikawa, M., & Takakura, Y. (2020). Development of CD40L-Modified Tumor Small Extracellular Vesicles for Effective Induction of Antitumor Immune Response. Nanomedicine, 15(17), 1641–1652. https://doi.org/10.2217/nnm-2020-0071

How many times has this paper been cited?

17 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Wen Liu, Yuki Takahashi, Masaki Morishita, Makiya Nishikawa, Yoshinobu Takakura.

What is the DOI of this paper?

10.2217/nnm-2020-0071, permanently at https://doi.org/10.2217/nnm-2020-0071. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.